Phase 2 Stomach Cancer Trial, Recruiting NCT05969860 Sponsor: Mayo Clinic Condition: Stomach Cancer
Back to Stomach Cancer

Phase 2 Stomach Cancer Trial, Recruiting

NCT05969860
Recruiting Phase 2

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years of age or older
  • You have been diagnosed with cancer that has been confirmed by a tissue biopsy (or, for liver cancer specifically, by imaging scans alone)
  • You have one of the many cancer types listed in the trial, including breast, lung, colon, prostate, ovarian, bladder, melanoma, lymphoma, and many others (confirm with trial site for the full list)
  • You are currently receiving one of the specific cancer treatment regimens listed in the trial as a standard, approved treatment for your cancer
  • Your doctor feels you have been tolerating your current cancer treatment well, with no serious reactions to your infusions
  • Your doctor expects you to continue your current treatment for at least 24 weeks from the start of the trial
  • You live within the service area covered by the trial's home care and paramedic network
  • Your home has Wi-Fi, or can support a wireless internet connection, to stay connected with the trial's remote monitoring team
  • You are physically well enough to carry out basic daily activities, either fully independently or with some limitations but still able to care for yourself (confirm with trial site)
  • You are able to complete questionnaires on your own or with help
  • You have signed a form agreeing to take part in the trial

Who may not be able to join:

  • You are currently taking part in another clinical trial that is treating your cancer
  • You need round-the-clock help with basic everyday tasks like washing, dressing, or eating
  • You are currently staying in hospital (unless you are already enrolled in a specific home-based care program)
  • You have other serious health conditions that, in your doctor's opinion, would make it unsafe for you to take part or would make it hard to properly monitor your treatment
  • You have an ongoing or active infection that is not under control
  • You have serious heart problems, such as heart failure with symptoms, unstable chest pain, an irregular heartbeat, or a heart attack within the last 6 months
  • You have a wound that is not healing properly
  • You have mental health or personal circumstances that would make it difficult to follow the trial's requirements

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Roxana S. Dronca, MD, Mayo Clinic

Phone: 855-776-0015

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 2
Sponsor
Registry
ClinicalTrials.gov
Start date
23 August 2023
Est. completion
1 January 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Mean patient-reported rating of Cancer Connected Access and Remote Expertise

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov